Analysis of PTEN complex assembly and identification of heterogeneous nuclear ribonucleoprotein C as a component of the PTEN-associated complex
- PMID: 19740742
- PMCID: PMC2781571
- DOI: 10.1074/jbc.M109.027995
Analysis of PTEN complex assembly and identification of heterogeneous nuclear ribonucleoprotein C as a component of the PTEN-associated complex
Abstract
PTEN (phosphatase and tensin homolog deleted on chromosome 10) is well characterized for its role in antagonizing the phosphoinositide 3-kinase pathway. Previous studies using size-exclusion chromatography demonstrated PTEN recruitment into high molecular mass complexes and hypothesized that PTEN phosphorylation status and PDZ binding domain may be required for such complex formation. In this study, we set out to test the structural requirements for PTEN complex assembly and identify the component(s) of the PTEN complex(es). Our results demonstrated that the PTEN catalytic function and PDZ binding domain are not absolutely required for its complex formation. On the other hand, PTEN phosphorylation status has a significant impact on its complex assembly. Our results further demonstrate enrichment of the PTEN complex in nuclear lysates, suggesting a mechanism through which PTEN phosphorylation may regulate its complex assembly. These results prompted further characterization of other protein components within the PTEN complex(es). Using size-exclusion chromatography and two-dimensional difference gel electrophoresis followed by mass spectrometry analysis, we identified heterogeneous nuclear ribonucleoprotein C (hnRNP C) as a novel protein recruited to higher molecular mass fractions in the presence of PTEN. Further analysis indicates that endogenous hnRNP C and PTEN interact and co-localize within the nucleus, suggesting a potential role for PTEN, alongside hnRNP C, in RNA regulation.
Figures
Similar articles
-
Protein kinase CK1alpha regulates mRNA binding by heterogeneous nuclear ribonucleoprotein C in response to physiologic levels of hydrogen peroxide.J Biol Chem. 2005 Apr 15;280(15):15340-7. doi: 10.1074/jbc.M500214200. Epub 2005 Feb 1. J Biol Chem. 2005. PMID: 15687492
-
ATM-mediated PTEN phosphorylation promotes PTEN nuclear translocation and autophagy in response to DNA-damaging agents in cancer cells.Autophagy. 2015;11(2):239-52. doi: 10.1080/15548627.2015.1009767. Autophagy. 2015. PMID: 25701194 Free PMC article.
-
Interference with the PTEN-MAST2 interaction by a viral protein leads to cellular relocalization of PTEN.Sci Signal. 2012 Aug 14;5(237):ra58. doi: 10.1126/scisignal.2002941. Sci Signal. 2012. PMID: 22894835
-
Regulation of the PTEN phosphatase.Gene. 2006 Jun 7;374:1-9. doi: 10.1016/j.gene.2006.02.024. Epub 2006 Mar 14. Gene. 2006. PMID: 16675164 Review.
-
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.Leukemia. 2011 Jul;25(7):1064-79. doi: 10.1038/leu.2011.46. Epub 2011 Mar 25. Leukemia. 2011. PMID: 21436840 Review.
Cited by
-
PTEN level in tumor suppression: how much is too little?Cancer Res. 2011 Feb 1;71(3):629-33. doi: 10.1158/0008-5472.CAN-10-2488. Epub 2011 Jan 25. Cancer Res. 2011. PMID: 21266353 Free PMC article. Review.
-
Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes.Oncotarget. 2016 Aug 2;7(31):49819-49833. doi: 10.18632/oncotarget.10454. Oncotarget. 2016. PMID: 27391443 Free PMC article.
-
The E3 ubiquitin ligase TRIM32 regulates myoblast proliferation by controlling turnover of NDRG2.Hum Mol Genet. 2015 May 15;24(10):2873-83. doi: 10.1093/hmg/ddv049. Epub 2015 Feb 20. Hum Mol Genet. 2015. PMID: 25701873 Free PMC article.
-
The virus-induced protein APOBEC3G inhibits anoikis by activation of Akt kinase in pancreatic cancer cells.Sci Rep. 2015 Jul 16;5:12230. doi: 10.1038/srep12230. Sci Rep. 2015. PMID: 26178819 Free PMC article.
-
Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer.Int J Mol Sci. 2013 Feb 1;14(2):3094-109. doi: 10.3390/ijms14023094. Int J Mol Sci. 2013. PMID: 23377018 Free PMC article.
References
-
- Li D. M., Sun H. (1997) Cancer Res. 57, 2124–2129 - PubMed
-
- Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S. I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S. H., Giovanella B. C., Ittmann M., Tycko B., Hibshoosh H., Wigler M. H., Parsons R. (1997) Science 275, 1943–1947 - PubMed
-
- Steck P. A., Pershouse M. A., Jasser S. A., Yung W. K., Lin H., Ligon A. H., Langford L. A., Baumgard M. L., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng D. H., Tavtigian S. V. (1997) Nat. Genet. 15, 356–362 - PubMed
-
- Maehama T., Dixon J. E. (1998) J. Biol. Chem. 273, 13375–13378 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials